Cannabis and Cannabinoid Research, the peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers, has announced a new collaborative partnership with the International Association for Cannabinoid Medicines. This new collaboration promotes the missions of the Journal and Association to further the science of clinical cannabis, cannabinoids, and the endocannabinoid system, for potential therapeutic and medical application.
For the past 16 years, the International Association for Cannabinoid Medicines (IACM) has been dedicated to advancing the knowledge on cannabis, cannabinoids, the endocannabinoid system, and related topics with regard to their therapeutic potential. The IACM organizes a highly regarded biennial Conference on Cannabinoids in Medicine.
Led by Editor-in-Chief Dr. Daniele Piomelli, Cannabis and Cannabinoid Research provides an important open access venue for publishing the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system. The journal publishes a broad range of human and animal studies, including basic and translational research; clinical studies; and behavioural, social, and epidemiological issues.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
